134
Views
8
CrossRef citations to date
0
Altmetric
Articles

Longitudinal assessment of D-dimer and plasminogen activator inhibitor type-1 plasma levels in pregnant women with risk factors for preeclampsia

, , , , , , , , & show all
Pages 58-63 | Received 29 Oct 2018, Accepted 17 Jan 2019, Published online: 13 Feb 2019

References

  • Abalos E, Cuesta C, Carroli G, et al. Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization multicountry survey on maternal and newborn health. BJOG. 2014 Mar;121 Suppl 1:14–24. PubMed PMID: 24641531.
  • American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Report of the American college of obstetricians and gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013 Nov;122(5):1122–1131. PubMed PMID: 24150027; eng.
  • Cetin I, Huppertz B, Burton G, et al. Pregenesys pre-eclampsia markers consensus meeting: what do we require from markers, risk assessment and model systems to tailor preventive strategies? Placenta. 2011 Feb;32 Suppl:S4–16. PubMed PMID: 21185077.
  • Ataullakhanov FI, Koltsova EM, Balandina AN, et al. Classic and global hemostasis testing in pregnancy and during pregnancy complications. Semin Thromb Hemost. 2016 Oct;42(7):696–716. PubMed PMID: 27652600.
  • McKay DG. Hematologic evidence of disseminated intravascular coagulation in eclampsia. Obstet Gynecol Surv. 1972 Jun;27(6):399–417. PubMed PMID: 4614142.
  • Roberts JM. Pathophysiology of ischemic placental disease. Semin Perinatol. 2014 Apr;38(3):139–145. PubMed PMID: 24836825; PubMed Central PMCID: PMCPMC4040272.
  • Chaiworapongsa T, Chaemsaithong P, Yeo L, et al. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014 Aug;10(8):466–480. PubMed PMID: 25003615; eng.
  • Ott P, Astrup L, Jensen RH, et al. Assessment of D-dimer in plasma: diagnostic value in suspected deep venous thrombosis of the leg. Acta Med Scand. 1988;224(3):263–267. PubMed PMID: 3239455.
  • Kruithof EK, Gudinchet A, Bachmann F. Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states. Thromb Haemost. 1988 Feb 25;59(1):7–12. PubMed PMID: 3129809.
  • Kopec G, Moertl D, Steiner S, et al. Markers of thrombogenesis and fibrinolysis and their relation to inflammation and endothelial activation in patients with idiopathic pulmonary arterial hypertension. PLoS One. 2013;8(12):e82628. PubMed PMID: 24312667; PubMed Central PMCID: PMCPMC3847115.
  • Shorr AF, Thomas SJ, Alkins SA, et al. D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients. Chest. 2002 Apr;121(4):1262–1268. PubMed PMID: 11948062.
  • Pedroja BS, Kang LE, Imas AO, et al. Plasminogen activator inhibitor-1 regulates integrin alphavbeta3 expression and autocrine transforming growth factor beta signaling. J Biol Chem. 2009 Jul 31;284(31):20708–20717. PubMed PMID: 19487690; PubMed Central PMCID: PMCPMC2742836.
  • Tripodi A, Mannucci PM. Markers of activated coagulation and their usefulness in the clinical laboratory. Clin Chem. 1996 May;42(5):664–669. PubMed PMID: 8653889.
  • Pinheiro MB, Junqueira DR, Coelho FF, et al. D-dimer in preeclampsia: systematic review and meta-analysis. Clin Chim Acta. 2012 Dec 24;414:166–170. PubMed PMID: 22922438.
  • Sa H, Sobel B, Benvenuto A, et al. Coagulation and fibrinolytic system protein profiles in women with normal pregnancies and pregnancies complicated by hypertension.Pregnancy Hypertens 2012 Apr 1;2(2):152–157. PubMed PMID: 22712057; PubMed Central PMCID: PMCPMC3375860.
  • Higgins JR, Walshe JJ, Darling MR, et al. Hemostasis in the uteroplacental and peripheral circulations in normotensive and pre-eclamptic pregnancies. Am J Obstet Gynecol. 1998 Aug;179(2):520–526. PubMed PMID: 9731863.
  • Kadir RA, Economides DL, Sabin CA, et al. Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptive. Thromb Haemost. 1999 Nov;82(5):1456–1461. PubMed PMID: 10595638.
  • Kline JA, Williams GW, Hernandez-Nino J. D-dimer concentrations in normal pregnancy: new diagnostic thresholds are needed. Clin Chem. 2005 May;51(5):825–829. PubMed PMID: 15764641. .
  • Hansen AT, Andreasen BH, Salvig JD, et al. Changes in fibrin D-dimer, fibrinogen, and protein S during pregnancy. Scand J Clin Lab Invest. 2011 Apr;71(2):173–176. PubMed PMID: 21190511.
  • Joly B, Barbay V, Jy B, et al. Comparison of markers of coagulation activation and thrombin generation test in uncomplicated pregnancies. Thromb Res. 2013 Sep;132(3):386–391. PubMed PMID: 23962423.
  • Murphy N, Broadhurst DI, Khashan AS, et al. Gestation-specific D-dimer reference ranges: a cross-sectional study. BJOG. 2015 Feb;122(3):395–400. PubMed PMID: 24828148.
  • Gerbasi FR, Bottoms S, Farag A, et al. Increased intravascular coagulation associated with pregnancy. Obstet Gynecol. 1990 Mar;75(3 Pt 1):385–389. PubMed PMID: 2137574.
  • Djurovic S, Clausen T, Wergeland R, et al. Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia. BJOG. 2002 Jul;109(7):759–764. PubMed PMID: 12135211.
  • Ajibola SO, Adeyemo TA, Afolabi BB, et al. Utility of a single mid-trimester measurement of plasminogen activator Type 1 and fibronectin to predict preeclampsia in pregnancy. Niger Med J. 2016 Jul-Aug;57(4):213–216. PubMed PMID: 27630384; PubMed Central PMCID: PMCPMC4995812.
  • Udenze IC, Arikawe AP, Makwe CC. Early pregnancy plasminogen activator inhibitor-1 levels in Nigerian women and its relationship with preeclampsia. Niger J Clin Pract. 2017 May;20(5):517–522. PubMed PMID: 28513507. .
  • Kb B, Biringer K, Dokus K, et al. Fibronectin, plasminogen activator inhibitor type 1 (PAI-1) and uterine artery doppler velocimetry as markers of preeclampsia. Dis Markers. 2011;30(4):191–196. PubMed PMID: 21694445; PubMed Central PMCID: PMCPMC3825071.
  • Belo L, Santos-Silva A, Rumley A, et al. Elevated tissue plasminogen activator as a potential marker of endothelial dysfunction in pre-eclampsia: correlation with proteinuria. BJOG. 2002 Nov;109(11):1250–1255. PubMed PMID: 12452463.
  • Ho CH, Yang ZL. The predictive value of the hemostasis parameters in the development of preeclampsia. Thromb Haemost. 1992 Feb 3;67(2):214–218. PubMed PMID: 1621241.
  • Pinheiro MB, Gomes KB, Dusse LM. Fibrinolytic system in preeclampsia. Clin Chim Acta. 2013 Feb 1;416:67–71.
  • Alpoim PN, Perucci LO, Godoi LC, et al. Oxidative stress markers and thrombomodulin plasma levels in women with early and late severe preeclampsia. Clin Chim Acta. 2018 Aug;483:234–238. PubMed PMID: 29723511.
  • Chappell LC, Seed PT, Briley A, et al. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol. 2002 Jul;187(1):127–136. PubMed PMID: 12114900.
  • Halligan A, Bonnar J, Sheppard B, et al. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia. Br J Obstet Gynaecol. 1994 Jun;101(6):488–492. PubMed PMID: 8018635.
  • Choi JW, Pai SH. Tissue plasminogen activator levels change with plasma fibrinogen concentrations during pregnancy. Ann Hematol. 2002 Nov;81(11):611–615. PubMed PMID: 12454697. .
  • Cadroy Y, Grandjean H, Pichon J, et al. Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia. Br J Obstet Gynaecol. 1993 May;100(5):416–420. PubMed PMID: 8518239.
  • Ballegeer V, Spitz B, Kieckens L, et al. Predictive value of increased plasma levels of fibronectin in gestational hypertension. Am J Obstet Gynecol. 1989 Aug;161(2):432–436. PubMed PMID: 2504045.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.